Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Autoantibody against transient receptor potential M1 cation channels of retinal ON bipolar cells in paraneoplastic vitelliform retinopathy

  • Yujuan Wang1, 2,
  • Mones S Abu-Asab1,
  • Wei Li3,
  • Mary E Aronow4,
  • Arun D Singh4 and
  • Chi-Chao Chan1Email author
BMC Ophthalmology201212:56

DOI: 10.1186/1471-2415-12-56

Received: 21 August 2012

Accepted: 7 November 2012

Published: 13 November 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
21 Aug 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
10 Sep 2012 Reviewed Reviewer Report - Anuradha Dhingra
14 Sep 2012 Reviewed Reviewer Report - John Heckenlively
31 Oct 2012 Author responded Author comments - Chi-Chao Chan
Resubmission - Version 3
31 Oct 2012 Submitted Manuscript version 3
Publishing
7 Nov 2012 Editorially accepted
13 Nov 2012 Article published 10.1186/1471-2415-12-56

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Section of Immunopathology, Laboratory of Immunology, National Eye Institute, National Institutes of Health
(2)
Zhongshan Ophthalmic Center, Sun Yat-sen University
(3)
Unit on Retinal Neurophysiology, National Eye Institute, National Institutes of Health
(4)
Department of Ophthalmic Oncology, Cole Eye Institute, Cleveland Clinic

Advertisement